Published in Blood Weekly, March 11th, 2004
"Five patients diagnosed as JMML were treated with a standard regimen (cytosine arabinoside (Ara-C) 100 mg/m2 per day continuous infusion (days 0-6), etoposide 100...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.